12-Week Study of Plecanatide for CIC (The National CIC3 Study)

NCT02122471 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1410

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Idiopathic Constipation

Interventions

DRUG: Plecanatide
DRUG: Placebo

Sponsor

Bausch Health Americas, Inc.